Wikipedia
Moleac
Moleac is a biopharmaceutical company which headquarters are located in Biopolis, a purpose built complex for biomedical sciences research in Singapore. Moleac brings together Asian and Western techniques by identifying medicine discovered in China and developing them into Western mainstream medicine. Moleac's first product, Neuroaid (also written NeuroAiD) is focused on brain stroke recovery and is derived from Traditional Chinese Medicine. It has gained market approval in two countries in 2006 and a clinical trial was started in October 2007 with 1100 patients (CHIMES study).